SpaceX Scrubs Starship 12th Test Flight Rescheduled for Friday Amid V3 Debut Morgan Stanley Maintains Bullish Stance on NextEra Energy Despite Price Target Reduction UK PM Starmer Pledges Social Media Crackdown Following Parent Meeting Regulation Uncertainty Looms IRS Settlement Blocks Tax Audits Targeting Trump and His Businesses Forum Energy Technologies FET Reports 8 Revenue Growth in First Quarter UBS Lifts Micron Price Target to Record High Stock Surges on Memory Sector Tailwinds Verastem Q1 2026 Earnings NarrowerthanExpected Loss Beats Estimates Stock Edges Higher BUSEP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Amid Modest Market Reaction CVCO Q1 2026 Earnings EPS Beats Estimates Amid Solid Housing Demand Teradyne Q1 2026 Earnings EPS Surges Past Estimates on Strong Demand Full Truck Alliance Co Ltd YMM Q1 2026 Earnings EPS Surges Past Estimates While Market Sentiment Remains Cautious Apple AAPL Q1 2026 Earnings EPS Beats Estimates as Services Strength Offsets Product Headwinds KVH Industries KVHI Sheds Over 6 Support and Resistance Levels in Focus Cosmos Health COSM Edges Lower Approaching Critical Support Amid Quiet Trading RLTY Rises as Real Estate Fund Holds Near MidRange Oculis Holding OCS Hovers Near Resistance as Biotech Sentiment Shifts Dare Bioscience DARE Edges Higher Amid Steady Support Levels UK Hottest Day of Year Boosts Travel Sectors Amid Bank Holiday Queues GWRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Intercure Ltd INCR Rallies 48 Testing Key Resistance at 097 Gain Therapeutics Inc Q1 2026 Earnings EPS Surprise Highlights Cost Discipline Amid PreRevenue Stage HOVR Q1 2026 Earnings EPS Misses Estimates PreRevenue Development Continues Stepan Company SCL Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher MARA Q1 2026 Earnings EPS Misses Estimates Amid Bitcoin Mining Challenges MSGE Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher Select Medical Holdings Q1 2026 Earnings EPS Misses Estimates Stock Flat INDP Q4 2025 Earnings EPS Misses Estimates as PreClinical Costs Continue Stock Declines 9